Interleukin-12 (IL-12) is critical for induction of protective immunity against intracellular bacterial infection. However, the mechanisms for efficient induction of IL-12 in innate response remain poorly understood. Here we report that the B type of carbonic anhydrase 6 (Car6-b, which encoded CA-VI B) is essential for host defense against Listeria monocytogenes (LM) infection by epigenetically promoting IL-12 expression independent of its carbonic anhydrase activity. Deficiency of Car6-b attenuated IL-12 production upon LM infection both in vitro and in vivo. Car6 −/− mice were more susceptible to LM infection with less production of IL-12. Mechanistically, the nuclear localized CA-VI B selectively promotes IL-12 expression by interaction with protein arginine N-methyltransferase 5 (PRMT5), which reduces symmetric dimethylation of histone H3 arginine 8 modification (H3R8me2s) at Il12 promoters to facilitate chromatin accessibility, selectively enhancing c-Rel binding to the Il12b promoter. Our findings add insights to the epigenetic regulation of IL-12 induction in innate immunity.
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Car6-b | IL-12 | PRMT5 | innate immunity | epigenetic modification I nnate immune response is critical for host defense against invading pathogens. Microbial and dangerous signals induce pattern-recognition receptor (PRR)-dependent activation of inflammatory signaling in innate immune cells such as macrophages and dendritic cells, leading to production of proinflammatory cytokines that display diversified immunological and inflammatory effects (1) . Of these, IL-12 plays essential roles in inducing transcription factor (TF) STAT4-dependent production of IFN-γ in natural killer (NK) cells and T cells, contributing to development of Th1 cell-mediated protective immunity against intracellular pathogens such as Mycobacterium tuberculosis (TB) and Listeria monocytogenes (LM) (2) . IL-12 expression is controlled by transcription activation of two separate genes, Il12a and Il12b, to form IL-12p70 with bioactivity. IL-12 deficiency results in defects in immune defense, causing increased susceptibility to infection by TB, Salmonella, or Candida both in humans and in mice (3) .
IL-12 is also related to development of autoimmune and inflammatory disease, as demonstrated by resistance to experimental autoimmune disorders in mice lacking Il12b (4). Antagonists against IL-12p40 have been verified to be an effective treatment for a number of autoimmune diseases in clinical or preclinical trials (5) . So the expression of IL-12 must be well balanced to achieve timely and effective protection against pathogenic infection. Further identification of new regulators of IL-12 production will contribute to a better understanding of the molecular basis for innate immunity against intracellular pathogens and also outline potential therapeutic strategies for control of infectious diseases.
Epigenetic mechanisms for gene expression during innate immunity and inflammation are attracting more and more attention now. Epigenetic regulations include DNA modifications, posttranslational modifications (PTMs) of histones, ATP-dependent chromatin remodeling, and noncoding RNA (ncRNA), which act in a coordinated manner to affect chromatin status and gene transcription and influence various immunological processes (6) . Expression of IL-12 is mainly dependent on TLR-triggered nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways (2). C-Rel, which belongs to the NF-κB family, is a key TF in mediating TLR-stimulated expression of IL-12 (7) . Histone methylation at the Il12b promoter is found to be important for IL-12 expression (8) . LPS stimulation also induces rapid remodeling of a positioned nucleosome at the Il12b promoter, which might be important for accessibility of specific TFs to the promoter region (7) . However, the detailed function of chromatin modifiers and transcription regulators in IL-12 expression and IL-12-mediated innate immunity in response to bacterial infections remains poorly understood.
Intracellular bacterial infection is one of the major health concerns today. For example, TB results in severe lung injury (9) . Also, the widely existed Gram-positive intracellular pathogen LM causes severe listeriosis and even death. LM has been used as a model organism for the study of intracellular pathogens (10) . LM mainly infects and induces IL-12 production in macrophages in vivo (11) . E-selectin is a key adhesion molecule encoded by Sele-mediating recruitment of Th1 cells into inflamed tissues (12) . To study LM-triggered innate response, we
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The immune system is important for host defense against invading pathogens by producing proinflammatory cytokines and IFNs. IL-12 is a vital proinflammatory cytokine that combines innate immunity with adaptive immunity. In our study, we find that CA-VI B preferentially expressed in macrophages can interact with PRMT5, consequently suppressing H3R8me2s modification in Il12 promoters to promote IL-12 production to trigger an antibacterial immune response. Our study adds insight about the function of CA family members in innate immune response by selectively inducing cytokine IL-12 production through regulating histone arginine modification, which is independent of its carbonic anhydrase activity.
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Data deposition: The cDNA microarray data are available at Gene Expression Omnibus (GEO) database, https://www.ncbi.nlm.nih.gov/geo/ (accession no. GSE90808). All original RNA-sequencing and ChIP-sequencing datasets have been submitted to the NCBI Sequence Read Archive (SRA) (accession nos. SRP108814 and SRP108823, respectively). compared mRNA expression in macrophages from Sele +/+ and Sele −/− mice infected with LM. Interestingly, Car6, which encoded CA-VI, was significantly decreased in Sele −/− macrophages. Car6 has two transcripts: One is the secreted A type of CA-VI A (encoded by Car6-a), and the other is intracellular CA-VI B. CA-VI belongs to the carbonic anhydrase (CA) family (13) . CA includes 16 members catalyzing the reversible hydration of CO 2 . CAs can be grouped into four kinds according to their different subcellular locations: CA-I, -II, -III, -VII, and -XIII are localized in cytoplasm; CA-IV, -IX, -XII, and -XIV are membrane-bound; CA-V is localized in mitochondria; and CA-VI is the only secreted CA (14) . Car6 might be involved in cellular oxidative stress in the submandibular gland and tissue homeostasis in the respiratory system and brain (15) . However, the roles of CAs in innate immunity remain unknown. Here, we demonstrated that Car6-b selectively promotes IL-12 expression by interaction with PRMT5 and consequently facilitates innate response against intracellular bacterial infection.
Results

Car6-b Is Preferentially Expressed in Macrophages and Inducible upon
Innate Stimuli. By cDNA microarray analysis of LM-infected peritoneal macrophages (PMs) from Sele −/− and Sele +/+ mice, we found mRNA expression of Car6 was significantly decreased in Sele −/− PMs ( Fig. S1 A and B) . We further analyzed the molecular mechanism of the impaired induction of Car6 mRNA in the absence of E-selectin. Given that E-selectin binds its ligands to activate the MAPK signaling pathway, to investigate the molecular mechanism behind how E-selectin engagement could upregulate Car6 expression, we used ERK-specific inhibitor FR180204 to pretreat PMs before infection of LM. We found that Car6 expression was reduced in the presence of the ERK inhibitor (Fig. S1C) , indicating that E-selectin engagement up-regulates Car6 expression via the ERK pathway.
As shown in Fig. 1A , the two types of Car6 have different transcription start sites (TSSs) and use disparate start codon ATG. Therefore, CA-VI A has an additional 57-aa peptide on the N terminus than CA-VI B does (13 (Fig. 1B) . We further confirmed that Car6-b expression in macrophages was higher than that in NKs and DCs by quantitative real-time PCR (qPCR) (Fig.  1C) . Furthermore, Car6-b was significantly induced by LM and LPS stimulation ( Fig. 1 D and E) . Confocal analysis indicated that CA-VI B was located in the nucleus of 293T cells (Fig. 1F) and PMs ( Fig.  1G ) with or without innate stimuli, which was consistent with the observation that CA-VI B is located in the nucleus of mouse embryo fibroblast cells in response to stress (13) . In addition, the enzyme catalytic mutant of Car6-b (M28+89) was also localized in the nucleus (Fig. 1F) . Taken together, Car6-b is preferentially expressed in macrophages and inducible upon innate stimuli.
Car6-b Selectively Promotes IL-12 Expression in Macrophages upon
Innate Stimuli. We next investigated the function of Car6-b in innate immune response. Given that only Car6-b but not Car6-a is expressed in macrophages, we silenced Car6-b in PMs ( Fig. S2A ) and found that LM-or LPS-induced Il12b, Il12a mRNA expression, and IL-12p70 production were dramatically reduced in Car6-b-silenced PMs ( Fig. 2 A-C) . IL-23 belongs to the IL-12 family and is composed of the IL-12p40 and IL-23p19 subunits. LM-and LPS-induced expression of Il23a (encoding IL-23p19) was also reduced by Car6-b knockdown (Fig. 2D) . However, silencing of Car6-b did not affect the production of IL-6 and TNF-α by PMs stimulated with LM or LPS ( Fig. S2 B-E). Data were shown as mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.
We next generated Car6-b −/− RAW264.7 cells by CRISPR/Cas9 technology (Fig. S3A) . As expected, LPS or LM-induced Il12b expression was significantly decreased in Car6-b −/− RAW264.7 cells compared with wild-type RAW264.7 cells (Fig. 2E) , whereas overexpression of Car6-b into Car6-b −/− RAW264.7 cells significantly rescued Il12b mRNA expression (Fig. 2F ) and IL-12p70 production (Fig. S2F) . However, IL-6 and TNF-α expressions were not affected by overexpression of Car6-b (Fig. S2 G and H) . We also found that transfection of Car6-a did not rescue the expression of Il12b mRNA (Fig. 2F ). In addition, overexpression of Car6-b remarkably promoted Il12b mRNA expression in RAW264.7 cells upon innate stimuli (Fig. 2G) .
To further investigate the role of Car6-b, we tried to generate Car6-b −/− mice. Given the structure shown in Fig. 1A , we could not knock out Car6-b specifically without influencing Car6-a. On the other hand, Car6-a is not expressed in immune cells, and Car6-b is the only type expressed. Therefore, we generated Car6 −/− mice in the C57BL/6J background using the CRISPRCas9 method (Fig. S3B) +/+ and Car6 −/− PMs stimulated with LM for 8 h (Fig. S5B ). Car6 −/− PMs had 887 genes up-regulated and 124 genes downregulated compared with Car6 +/+ PMs after stimulation with LM. We then analyzed the immune-related genes and found that II12b was down-regulated in Car6 −/− PMs after stimulation by LM (Fig.  3A) . However, there were no significantly different expressions of other cytokines, including Il6, Tnf, Il1, and Il10, between Car6 +/+ and Car6 −/− PMs, which was further confirmed by qPCR. Notably, LM-or LPS-induced Il12b, Il12a, and Il23a mRNA expression and IL-12p70 production were significantly decreased in Car6 −/− PMs compared with Car6 +/+ PMs (Fig. 3 B-E ). In addition, Car6 deficiency did not affect innate signal-induced production of IL-6 and TNF-α (Fig. S5 C-F) , and Car6-b deficiency did not affect the expression of Nos2, Ifnb1, Il1a, and Cd80 in Car6 −/− PMs compared with that in Car6 +/+ PMs after innate stimuli (Fig. S5  G-J) . The innate signal-induced expression of Il12b mRNA was also significantly reduced in Car6 −/− bone marrow-derived macrophages (BMMs) (Fig. S6A) but not in bone marrowderived DCs (BMDCs) (Fig. S6B) . Taken together, we demonstrate that Car6-b selectively promotes IL-12 expression in macrophages upon innate stimuli.
Car6-b
+/+ and Car6 −/− mice with the lethal load of LM by i.p. injection. The survival rate of Car6 −/− mice was much lower than that of Car6 +/+ mice after LM infection (Fig. 4A) , consistent with the increased bacterial load in various organs and more obvious infiltration of mononuclear inflammatory cells in the lungs of Car6 −/− mice (Fig. 4 B and C) . Moreover, a much lower level of serum IL-12p70 and IFN-γ but similar levels of IL-6 and TNF-α production were detected in Car6 −/− mice (Fig. 4D) . Therefore, Car6-b significantly protected mice from LM infection by selectively promoting IL-12 production in vivo.
Car6-b Promotes IL-12 Production Independent of Its CA Activity and Not via NF-κB/MAPK Pathways. We wondered whether the underlying mechanism for Car6-b selectively promotes IL-12 expression in innate response. CA-VI A is secreted into saliva to maintain pH homeostasis by its CA enzyme activity (16) , and CA-VI B also contains this enzyme domain. We wondered whether the pH of cytoplasm and the nucleus of PM might be involved in Car6-bmediated promotion of IL-12 expression. However, there was no obvious difference in pH in either the cytoplasm or the nucleus of Car6 +/+ and Car6 −/− PMs with or without infection (Fig. S7) . We also constructed catalytically inactive mutant Car6-b-M28+89 (H28A, Y89A) and found that Car6-b-M28+89 displayed a similar function as wild-type Car6-b in rescuing the Il12b mRNA expression (Fig. 2F) and IL-12p70 production (Fig. S2F ) in Car6-b −/− RAW264.7 cells. However, the catalytically active Car6-a did not rescue the IL-12 expression. These results showed that Car6-b promotes IL-12 expression independent of its CA catalytic activity.
NF-κB and MAPK signaling pathways are known to induce the expression of IL-12 (2). However, no obvious difference was found in the activation of the inhibitor of NF-κB (IκB), kinase (IKK), TF (c-Rel), MAPKs (ERK, JNK, and p38) (Fig. S8 A-D) , or the nucleus translocation of c-Rel, p65, and C/EBPβ (Fig. S8  E and F) between Car6 −/− and Car6 +/+ PMs upon LM or LPS Data were shown as mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. shown as mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.
stimuli. Therefore, Car6-b does not affect NF-κB and MAPK signaling pathways.
Car6-b Promotes c-Rel Recruitment to the Il12 Promoter upon Innate
Stimuli. Based on the critical function of c-Rel in transcription of genes encoding IL-12 and other cytokines, we performed luciferase Il12b reporter assay to explore the detailed mechanism of Car6-bpromoted IL-12 production. Ectopic expression of Car6-b had no effect on transcriptional activity of the Il12b reporter that was induced by c-Rel, and Car6-b itself had no function on Il12b reporter (Fig. 5A) , nor did CA-VI B interact with c-Rel in HEK293T cells as detected by co-immunoprecipitation (co-IP) assay (Fig. 5B) . Thus, Car6-b might not directly affect c-Rel transcriptional activity.
To clarify whether Car6-b affects chromatin conformation, we detected the DNA accessibility of the Il12b promoter by DNase I sensitivity analysis (17) . Interestingly, DNA accessibility of the Il12b promoter was significantly decreased in Car6 −/− PMs upon innate stimuli (Fig. 5C ). We also found that the chromatin accessibility of promoter sites of Il6 and Tnf was not influenced by Car6 deficiency in PMs upon innate stimuli (Fig. 5 D and E) . C-Rel particularly binds to the region containing an NF-κB binding site of the Il12b promoter (8) . Therefore, we performed chromatin immunoprecipitation (ChIP) assay to examine c-Rel binding to the region between position -150 and -50 of the Il12b promoter, which contains an NF-κB binding site. We found that the recruitment of c-Rel to the promoter of Il12b was substantially decreased in Car6 −/− PMs stimulated with LM or LPS (Fig. 5F ). However, recruitment of c-Rel to the promoters of Il6 and Tnf was comparable between Car6 +/+ and Car6 −/− PMs upon innate stimuli ( Fig. 5 G and H) . Collectively, we demonstrate that Car6-b selectively promotes chromatin accessibility to facilitate c-Rel binding to the Il12b promoter.
CA-VI B Associates with PRMT5 to Promote c-Rel Recruitment to Il12
Promoters by Histone Modification. Because CA-VI B is located in the nucleus of macrophages and promotes c-Rel recruitment to the Il12b promoter, we speculated that Car6-b might be involved in histone modification to regulate chromatin accessibility. We performed mass spectrometry screening of the candidate proteins interacting with CA-VI B in HEK293T cells (Fig. S9 A-C) . One potential candidate, PRMT5, attracted our attention. PRMT5, a type II arginine methyltransferase that symmetrically dimethylates arginine residues on histone H2AR3, H3R8, and H4R3, has been reported to regulate gene transcription through histone modification (18) . Importantly, methylosome protein 50 (MEP50/WDR77) is required for PRMT5 function (19) .
Co-IP experiments confirmed that Flag-tagged Car6-b interacted with both Myc-tagged PRMT5 and V5-tagged MEP50 (Fig. S9D) . Moreover, we performed co-IP experiments to confirm the interaction between endogenous Car6-b and PRMT5 using CA-VI antibody in the lysates of Car6 +/+ and Car6 −/− PMs with or without LM stimulation (Fig. 6A) . By immunofluorescence, we identified that CA-VI B and PRMT5 were colocalized in the nucleus of PMs after stimulation with LM or LPS (Fig. S9E) . By proximal ligation assay (PLA), we further confirmed the interaction of CA-VI B and PRMT5 in the nucleus of Car6 +/+ PMs but not in Car6 −/− PMs or PRMT5-slienced Car6 +/+ PMs (Fig. 6B) . To further investigate the interaction site of CA-VI B and PRMT5, we constructed C-terminal deletion Car6-b (ΔC)-, N-terminal deletion Car6-b (ΔN)-, and N-terminal deletion PRMT5 (ΔN)-expressing plasmids. Our co-IP experiment showed that the C-terminal domain of Car6-b was indispensable for its interaction with the N-terminal domain of PRMT5 (Fig. S9 F and G) . Furthermore, Car2 and Car13 were expressed in macrophages and located in the cytoplasm (14) . So we constructed Car2-and Car13-expressing plasmids to detect the interaction with PRMT5. We found only Car6-b interacted with PRMT5 but not Car2 and Car13 (Fig. S9H) . These data showed the specificity interaction between Car6-b and PRMT5, and overexpression of Car6-b ΔC did not promote IL-12 expression in RAW264.7 Car6-b KO cells upon LM stimulation (Fig. S9I) . Furthermore, overexpression of Car6-b ΔC did not promote IL-12 expression in RAW264.7 and did not show dominant negative effects (Fig. S9J) . These results indicate that the C-terminal domain is essential for Car6-b to interact with the N-terminal domain of PRMT5 and promotes IL-12 expression. Thus, Car6-b binds the same domain of PRMT5 as MEP50 (19) . To further clarify whether Car6-b affected the activity of PRMT5, we used PRMT5 antibody for co-IP in RAW264.7 cells and found that PRMT5 interaction with Car6-b increased after innate stimuli. However, the interaction between PRMT5 and MEP50 was reduced simultaneously (Fig.  6C) . As known, MEP50 is necessary for PRMT5 activity (19) . Thus, Car6-b and MEP50 competitively interact with PRMT5, which leads to a decrease in the PRMT5 activity.
Furthermore, we performed ChIP assay to detect the recruitment of PRMT5 in promoters of Il12b, Il6, and Tnf. We found that the recruitment of PRMT5 to the Il12b promoter site was increased in Car6 −/− PMs (Fig. 6D) . However, the recruitment of PRMT5 to the promoters of Il6 and Tnf was not affected in Car6 −/− PMs (Fig. 6 E  and F) . Furthermore, we used PRMT5 antibody for ChIP-seq of Car6 +/+ and Car6 −/− PMs with or without LM stimulation. We found PRMT5 consensus-binding element AAAAAAAAAAAA in Il12b promoter sites but not in Il6 and Tnf promoters (Fig. S9K) . Additionally, we silenced Prmt5 in Car6 +/+ and Car6 −/− PMs and found that silenced Prmt5 in Car6 −/− PMs selectively promoted IL-12 production and did not affect IL-6 and TNF-α production upon innate stimuli (Fig. S10) . These results suggested Car6-b selectively regulated IL-12 expression by interaction with PRMT5, which is specifically recruited to the Il12b promoter. We further elucidate were shown as mean ± SD (n = 3). *P < 0.05, **P < 0.01.
whether histone arginine methylation on promoters of Il12b and Il12a was regulated by CA-VI B and PRMT5. Indeed, H3R8me2s of Il12b and Il12a promoters were significantly increased in Car6 −/− PMs upon innate stimuli (Fig. 6 G and H) . In addition, we also found that trimethylation of histone H3 lysine 4 (H3K4me3) at the Il12b promoter was significantly decreased in Car6 −/− PMs upon innate stimuli (Fig. 6I) . Taken together, CA-VI B inhibits H3R8me2s modification at promoters of Il12 genes by interaction with PRMT5, which increases the chromatin accessibility upon innate stimuli, consequently enhancing c-Rel binding to the promoter of Il12b and promoting IL-12 expression.
Discussion IL-12 is mainly produced by activated macrophages, monocytes, and DCs (2). Here we identify a previously unknown role of Car6-b in promoting host defense against bacterial infection by selectively enhancing IL-12 expression via interaction with PRMT5 to inhibit arginine methylation at Il12 promoter regions. This is a report about the function of CA members in innate immune response by selectively inducing IL-12 production independent of its CA activity.
Car6 has two types. In our study, we demonstrate that only Car6-b is expressed in the immune system and preferentially expressed in macrophages. A previous report showed that the mRNA expression of Car6 was up-regulated in Helicobacter pylori-infected RAW264.7 cells (20) . Car6-b located in the nucleus has been discovered in mouse embryo fibroblasts in response to stress by unknown mechanisms, whereas its biological functions in the immune system remain unknown. Our study uncovered the function of Car6-b in innate immune response.
Car6-b deficiency particularly impairs IL-12 production in macrophages upon innate stimuli but not in DCs. This cell-type selectivity is consistent with the higher Car6-b expression in macrophages than that in DCs. DCs and macrophages show different developmental and functional properties in the regulation of innate and adaptive immunity (21) . The mechanisms for IL-12 production in DCs and macrophages are different upon different TLR signaling (22). The selective role of Car6-b may thereby provide a new mechanism for the differential capacity of DC and macrophages in IL-12 production upon different innate stimuli.
The NF-κB complex contains RelA (p65), RelB, c-Rel, p100, and p105. C-Rel is expressed in hematopoietic cells (23) , which might contribute to cell type-specific expression or function of many innate signaling regulators. C-Rel is necessary for Il12b transcription in macrophages, whereas Il12a is c-Rel-dependent in DCs (24, 25) . Both Il6 and Tnf expression are mainly regulated by activation of p65 and p38 in NF-κB and MAPK signaling pathways, although c-Rel also has some functions in this process (23, 26) . Both p50/p65 and p50/c-Rel bind to the promoter of Il12b, whereas c-Rel has a crucial role in induction of IL-12 expression in macrophages compared with p65 (7, 25) . Consistently, deletion of Car6-b neither inhibits the production of TNF-α and IL-6 in macrophages upon LM or LPS stimulation nor affects c-Rel binding to the promoter region of Tnf and Il6. Indeed, the selectivity of regulating gene expression by epigenetic and transcriptional mechanisms has long been a challenging issue in the field. A complex cooperation is shown to be involved in the dynamic and spatial regulation of gene expression. For example, induction of de novo 5-hydroxymethylation upstream of the Il6 locus by methylcytosine dioxygenase TET2 recruits HDAC2 to specifically inhibit Il6 transcription via histone deacetylation and therefore is critical for termination of the high transcription of Il6 during the late phase of inflammatory response (27) . In addition, there is a report showing that linc RNA-Cox2 can regulate Il12b expression (28) . Our work showed that CA-VI B competitively binds PRMT5 with MEP50 to reduce the methylation activity of PRMT5 specifically recruited to the promoter of Il12b, leading it to selectively regulate Il12 production in innate immune response.
Lysine methylation modification on histone has been extensively investigated, whereas the role of arginine methylation on histone in regulation of immune response has not been clearly clarified. In the present study, we identified that CA-VI B inhibited H3R8me2s at the Il12 promotor region by interaction with PRMT5, thus adding insights into this histone modification type in regulation of innate immunity and inflammation. Increased activity of the PRMT5-MEP50 complex is found in many kinds of cancer cells and highly correlated with poor prognosis of human cancers, and it is the potential target for treatment of cancers (19) . PRMT5 participates in inflammatory response by methylation modification of R35 or R30 of p65 to regulate interleukin-1α (IL-1α), TNF receptor-associated factor 1 (TRAF1), or CXCL10 expression (29) . H3R8me2s and H4R3me2s repress gene expression, although the mechanisms mediated with PRMT5 remain to be elucidated (30) . Our study reports PRMT5 in regulation of IL-12 expression by arginine modification of histone. Moreover, a crosstalk between arginine and lysine methylation exists to regulate gene expression (31) . We found decreased H3K4me3 modification at the Il12b promoter in Car6-b −/− macrophages upon innate stimuli. Further investigations are required to uncover whether and how H3K4me3s and H3R8me2s, and possibly other types of histone modifications, may interact to regulate IL-12 expression.
According to published gene-profiling data, Car6 expression is up-regulated in inflammatory macrophages in an acute TB infection mouse model (1.3-fold higher than that of control cells; GEO accession no. GSE23014). In addition, Car6 is down-regulated in chronic TB infection (1.3-fold lower than that of acute infection period patients, GEO accession no. GSE54992). Moreover, IL-12 is induced in macrophages in response to Toxoplasma gondii infection (32) . Car6 expression is also up-regulated in T. gondii-infected RAW 264.7 cell lines (1.4-fold higher than that of their control cells; GEO accession no. GSE55298) and in zymosan-induced active macrophages (1.2-fold higher than that of control cells; GEO accession no. GSE28621). These data indicate that Car6 can be upregulated in acute infection, helping the host to defend against the invading pathogens, whereas down-regulation of Car6 expression may be one of the reasons for the host with chronic infection not to effectively eliminate the invading pathogens. These data, together with our results, suggest a potentially important connection between Car6 and human infection diseases and a possible clinical application of activating Car6 in treatment of chronic infectious disease with intracellular bacterial infection.
Materials and Methods
Mice. C57BL/6J mice were purchased from Beijing Vital River Animal Center. Car6 −/− mice were generated by using the CRISPR/Cas9 system. Car6 −/− mice generation information is described in SI Materials and Methods. All animal protocols were approved by the Animal Care and Use Committees of the Institute of Laboratory Animal Science of Chinese Academy of Medical Sciences (ILAS-GC-2015-002).
In Vivo Challenge with Listeria Monocytogenes. LMs were obtained and cultured as described previously (33) . Mice were infected with 5 × 10 4 virulent
LMs intraperitoneally. Bacteria in the spleen, liver, and lung were quantified as described previously (33) .
ChIP. PMs were processed according to the protocol described in the ChIP Assay kit (Beyotime P2078). Antibody-chromatin complexes were pulled down using magnetic protein G beads (Invitrogen), washed, and then eluted. After cross-link reversal and protein K treatment, immunoprecipitated DNA was extracted with phenol-chloroform and ethanol-precipitated. ChIP primers used for Il12a were described previously (8) , and for Il6, Tnfs were similar to ref. 27 . Other mouse primers were as follows: Il12b pro (0-0.2K) forward, 5′-GGGGAGGGAGGAACTTCTTA-3′; Il12b pro (0-0.2K) reverse, 5′-TGATGGAAACCCAAAGTAGAAACTGAC-3′.
Chromatin Accessibility (DNase I Sensitivity) Assay. Chromatin accessibility assay and analysis were performed as described previously (17) . In brief, chromatin accessibility of the Il12b promoter region in Car6 +/+ and Car6 −/− macrophages stimulated with LPS for 1 h or LM for 3 h were assayed by qPCR.
Transfection. Cells were seeded and kept overnight, and then RNAi MAX was used for gene-specific siRNA transfection for 36-48 h. Jetprime (Poly plus) and lipofectamine 3000 transfection reagent (Invitrogen) were used for transfection in 293T cells and RAW264.7 cells, respectively.
Statistical Analysis. Statistical significance between two-group comparisons was analyzed by two-tailed Student t test. The statistical significance of survival curves was compared with the generalized Wilcoxon test. The value P < 0.05 was considered statistically significant. Additional methods are described in SI Materials and Methods.
